Paediatric Subanalysis of TSUBASA, Assessing Physical Activity, Bleeding, Quality of Life and Safety in People with Haemophilia A Receiving Emicizumab
TH Open · 21.01.2026 · 10 (CP)
DOI: 10.1055/a-2781-8278 ↗Kurz gefasst
Fachartikel in der Zeitschrift TH Open, erschienen am 21.01.2026. Verfasst von Keiji Nogami und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nara Medical University, Nara, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Limited data are available on the relationship between bleeding outcomes and physical activity, and the quality of daily life (QoL), in children with haemophilia A (HA) receiving emicizumab prophylaxis. TSUBASA evaluated physical activity, bleeding events, safety, and QoL in Japanese people with HA initiating emicizumab prophylaxis. This paper reports the results from the final analysis, focusing on children and adolescents with HA without factor VIII inhibitors, and their caregivers. TSUBASA was a prospective, multicentre, observational study conducted across 50 medical institutions in Japan. Participants received emicizumab for 97 weeks. Bleeding events and physical activity data were obtained using an electronic patient-reported outcomes application; activity intensity was collected by wearable activity trackers worn over five 8-day monitoring periods. Adverse events (AEs) were documented on the electronic case report form and QoL was assessed using questionnaires. A total of 46 participants aged
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Nara Medical University, Nara, Japan.
- Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
- Department of Respiratory Medicine and Hematology, Hyogo Medical University, Hyogo, Japan.
- Department of Hematology and Oncology, Kansai Medical University Hospital, Osaka, Japan.
- Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan.
- Department of Pediatrics, St. Marianna University School of Medicine, Kanagawa, Japan.
ORCID-Profile: Azusa Nagao
Zitieren
APA
Nogami, K., Amano, K., Sawada, A., Nagao, A., Nagae, C., Nojima, M., Suzuki, N., Kawano, M., Shimura, T., Sugao, Y., & Fujii, T. (2026). Paediatric Subanalysis of TSUBASA, Assessing Physical Activity, Bleeding, Quality of Life and Safety in People with Haemophilia A Receiving Emicizumab. TH Open, 10(CP). https://doi.org/10.1055/a-2781-8278
Vancouver
Nogami K, Amano K, Sawada A, Nagao A, Nagae C, Nojima M, et al. Paediatric Subanalysis of TSUBASA, Assessing Physical Activity, Bleeding, Quality of Life and Safety in People with Haemophilia A Receiving Emicizumab. TH Open. 2026;10(CP). doi:10.1055/a-2781-8278
BibTeX
@article{Nogami2026,
author = {Nogami, Keiji and Amano, Kagehiro and Sawada, Akihiro and Nagao, Azusa and Nagae, Chiai and Nojima, Masanori and Suzuki, Nobuaki and Kawano, Mika and Shimura, Tomomi and Sugao, Yoshimasa and Fujii, Teruhisa},
title = {Paediatric Subanalysis of TSUBASA, Assessing Physical Activity, Bleeding, Quality of Life and Safety in People with Haemophilia A Receiving Emicizumab},
journal = {TH Open},
year = {2026},
volume = {10},
number = {CP},
doi = {10.1055/a-2781-8278}
}
EUVIMED